Show simple item record

dc.contributor.authorVestjens, Stefan M T
dc.contributor.authorSanders, Elisabeth A M
dc.contributor.authorVlaminckx, Bart J
dc.contributor.authorde Melker, Hester E
dc.contributor.authorvan der Ende, Arie
dc.contributor.authorKnol, Mirjam J
dc.date.accessioned2019-10-04T08:13:10Z
dc.date.available2019-10-04T08:13:10Z
dc.date.issued2019-10-08
dc.identifier.issn1873-2518
dc.identifier.pmid31500963
dc.identifier.doi10.1016/j.vaccine.2019.08.025
dc.identifier.urihttp://hdl.handle.net/10029/623281
dc.language.isoenen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subject10-valent pneumococcal vaccinationen_US
dc.subjectClinical outcomeen_US
dc.subjectInvasive pneumococcal diseaseen_US
dc.subjectNational immunisation programmeen_US
dc.subjectThe Netherlandsen_US
dc.titleTwelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease.en_US
dc.typeArticleen_US
dc.identifier.journalVaccine 2019; advance online publication (ahead of print)en_US
dc.source.journaltitleVaccine


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record